Coherus BioSciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Coherus BioSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q4 2024.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$50.7M, a 36.4% increase year-over-year.
  • Coherus BioSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $28.5M.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was $28.5M.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$238M, a 18.5% increase from 2022.
  • Coherus BioSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$292M, a 1.62% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $28.5M -$50.7M +$29M +36.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 -$450K -$10.8M +$28.9M +72.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$29.3M -$12.9M +$29.9M +69.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$59.3M $103M +$179M Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$238M -$79.7M -$20.8M -35.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 -$217M -$39.6M +$47M +54.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$264M -$42.9M +$7.28M +14.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$271M -$75.7M +$20.4M +21.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$292M -$58.9M -$13.1M -28.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-17
Q3 2022 -$279M -$86.7M -$48.1M -125% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$230M -$50.2M -$20.3M -67.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$210M -$96.1M +$76.9M +44.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$287M -$45.7M -$55.4M -571% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$232M -$38.5M -$66.5M -238% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$165M -$29.9M -$88.9M -151% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$76.3M -$173M -$209M -586% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 $132M $9.71M -$29.5M -75.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $162M $27.9M -$19.1M -40.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $181M $59M +$35.5M +150% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 $145M $35.6M +$55.6M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 $89.8M $39.2M +$102M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 -$12M $47M +$106M Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-08
Q2 2019 -$118M $23.6M +$67.2M Apr 1, 2019 Jun 30, 2019 10-Q 2019-11-08
Q1 2019 -$185M -$20M +$24.3M +54.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$209M -$62.6M -$13.5M -27.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$196M -$58.8M +$181K +0.31% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$196M -$43.6M +$11.7M +21.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$208M -$44.3M +$30.5M +40.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$238M -$49.1M +$26.9M +35.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$265M -$59M -$143M -170% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$122M -$55.3M +$14.6M +20.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$137M -$74.8M -$9.39M -14.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$127M -$75.9M -$23.5M -44.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$104M $83.9M +$155M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$259M -$70M -$11.2M -19% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$248M -$65.4M -$24.7M -60.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$223M -$52.4M -$23.3M -79.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$200M -$71.3M -$63.5M -806% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$137M -$58.8M -$33.9M -136% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$103M -$40.7M -$15.6M -61.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$87.1M -$29.1M -$14.5M -99.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$72.6M -$7.87M +$13.6M +63.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$86.2M -$25M -$16.2M -187% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$69.9M -$25.2M -$16.3M -184% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$53.6M -$14.6M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 -$21.5M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-23
Q2 2013 -$8.71M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-23
Q1 2013 -$8.86M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.